Feedback / Questions
Fakzynja (defactinib) - Verastem
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03727880
Feb 5, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next